Susquehanna International Group’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105K Buy
+26,300
New +$117K ﹤0.01% 12316
2025
Q3
Sell
-12,800
Closed -$60.7K 13804
2025
Q2
$60.7K Sell
12,800
-3,800
-23% -$17.8K ﹤0.01% 12048
2025
Q1
$78.5K Sell
16,600
-10,800
-39% -$62.9K ﹤0.01% 11685
2024
Q4
$190K Buy
27,400
+4,600
+20% +$33.7K ﹤0.01% 10784
2024
Q3
$132K Buy
+22,800
New +$138K ﹤0.01% 10852
2023
Q1
Sell
-87,800
Closed -$651K 13464
2022
Q4
$651K Sell
87,800
-111,000
-56% -$1M ﹤0.01% 7195
2022
Q3
$2.49M Buy
198,800
+20,300
+11% +$243K ﹤0.01% 4468
2022
Q2
$1.37M Buy
178,500
+36,400
+26% +$306K ﹤0.01% 5766
2022
Q1
$1.44M Buy
142,100
+91,800
+183% +$839K ﹤0.01% 6241
2021
Q4
$363K Buy
50,300
+37,700
+299% +$206K ﹤0.01% 10028
2021
Q3
$45K Buy
+12,600
New +$46.1K ﹤0.01% 12381

Other funds holding SRTS

Susquehanna International Group's SRTS Position: Q1 2026 in Review

Susquehanna International Group sold out of Sensus Healthcare (SRTS) in Q1 2026, closing a stake of 47,680 shares — an estimated $212K sold.

Susquehanna International Group first reported a position in SRTS in Q1 2019 and held it in 14 quarters. The position peaked at $455K in Q1 2025. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

  • Susquehanna International Group reported no remaining Sensus Healthcare position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 47,680 Sensus Healthcare shares in Q1 2026, an estimated $212K.
  • Susquehanna International Group first reported a position in Sensus Healthcare in Q1 2019 and held it in 14 quarters.
  • Susquehanna International Group's Sensus Healthcare position peaked at $455K in Q1 2025.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.